WallStreetZenWallStreetZen

NASDAQ: LFCR
Lifecore Biomedical Inc Stock

$1.67-3.44 (-67.32%)
Updated Mar 17, 2023
LFCR Price
$1.67
Fair Value Price
$5.25
Market Cap
$50.63M
52 Week Low
$1.52
52 Week High
$11.96
P/E
-0.36x
P/B
0.68x
P/S
1.36x
PEG
N/A
Dividend Yield
N/A
Revenue
$182.86M
Earnings
-$90.56M
Gross Margin
21.1%
Operating Margin
-41.72%
Profit Margin
-49.5%
Debt to Equity
2.76
Operating Cash Flow
-$25M
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

LFCR Overview

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LFCR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LFCR ($1.67) is undervalued by 68.21% relative to our estimate of its Fair Value price of $5.25 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
LFCR ($1.67) is significantly undervalued by 68.21% relative to our estimate of its Fair Value price of $5.25 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
LFCR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LFCR due diligence checks available for Premium users.

Be the first to know about important LFCR news, forecast changes, insider trades & much more!

LFCR News

Valuation

LFCR fair value

Fair Value of LFCR stock based on Discounted Cash Flow (DCF)
Price
$1.67
Fair Value
$5.25
Undervalued by
68.21%
LFCR ($1.67) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LFCR ($1.67) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LFCR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LFCR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.36x
Industry
16.18x
Market
21.81x

LFCR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
4.75x
LFCR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LFCR's financial health

Profit margin

Revenue
$38.8M
Net Income
-$12.4M
Profit Margin
-32.1%
LFCR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LFCR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$279.1M
Liabilities
$204.9M
Debt to equity
2.76
LFCR's short-term liabilities ($195.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LFCR's short-term assets ($127.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LFCR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
LFCR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
-$3.3M
Financing
$8.8M
LFCR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LFCR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LFCR$50.63M-67.32%-0.36x0.68x
PMCB$50.59M+0.69%-11.15x0.66x
PRTG$50.19M-5.16%-2.49x0.30x
BCEL$50.01M-6.57%-0.46x0.52x
LTRN$51.57M-3.46%-3.63x0.87x

Lifecore Biomedical Stock FAQ

What is Lifecore Biomedical's quote symbol?

NASDAQ: LFCR) Lifecore Biomedical trades on the NASDAQ under the ticker symbol LFCR. Lifecore Biomedical stock quotes can also be displayed as NASDAQ: LFCR.

If you're new to stock investing, here's how to buy Lifecore Biomedical stock.

What is the 52 week high and low for Lifecore Biomedical (NASDAQ: LFCR)?

(NASDAQ: LFCR) Lifecore Biomedical's 52-week high was $11.96, and its 52-week low was $1.52. It is currently -86.03% from its 52-week high and 9.87% from its 52-week low.

How much is Lifecore Biomedical stock worth today?

(NASDAQ: LFCR) Lifecore Biomedical currently has 30,319,208 outstanding shares. With Lifecore Biomedical stock trading at $1.67 per share, the total value of Lifecore Biomedical stock (market capitalization) is $50.63M.

Lifecore Biomedical stock was originally listed at a price of $3.50 in Dec 31, 1997. If you had invested in Lifecore Biomedical stock at $3.50, your return over the last 25 years would have been -52.29%, for an annualized return of -2.92% (not including any dividends or dividend reinvestments).

How much is Lifecore Biomedical's stock price per share?

(NASDAQ: LFCR) Lifecore Biomedical stock price per share is $1.67 today (as of Mar 17, 2023).

What is Lifecore Biomedical's Market Cap?

(NASDAQ: LFCR) Lifecore Biomedical's market cap is $50.63M, as of Mar 20, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lifecore Biomedical's market cap is calculated by multiplying LFCR's current stock price of $1.67 by LFCR's total outstanding shares of 30,319,208.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.